Oncology nutrition deals with managing the nutritional intake of patients suffering from cancer to support the treatment and reduce its side effects. The rising incidence of cancer and increasing expenditure on healthcare due to changing lifestyles are expected to drive the growth of this market. According to the Centers for Disease Control and Prevention, for every 1,00,000 people, 439 new cancer cases were reported in the U.S. in 2019.
Moreover, increasing investment in research and continuous development in technology and treatment are opportunities for players operating in the oncology nutrition market. On the other hand, a lack of knowledge and understanding regarding oncology nutrition can hinder its growth. The disruption in the supply chain worldwide and the change in consumer behavior due to the COVID-19 pandemic also affected the growth of this market.
The market is driven by continuous innovation, investment in research and development, merger & acquisition, and new product launches to improve the effectiveness of nutrition and oncology treatment. In September 2019, Smartfish AS, a leading player in the oncology nutrition market, announced a collaboration with B. Braun, a company operating in the healthcare sector, to launch its nutritional product Remune. The product has shown remarkable results during clinical trials on cancer patients. Other key players in the market include FMC Corporation; Global Health Products, Inc; Baxter; Danone India; Mead Johnson & Company; Abbott; and Aceto.
The oncology nutrition market can be classified based on the type of cancer, which includes lung cancer, head and neck cancer, stomach cancers, liver cancer, blood cancer, and others; by nutrition, including enteral nutrition and parenteral nutrition; by formula including standard, elemental and specialized; by distribution channels such as hospital pharmacy, online pharmacy, and retail pharmacy. Based on region, the market can be segmented into North America, South America, Europe, Asia Pacific, and Middle East and Africa.
By Cancer Type
Head And Neck Cancer
Stomach and Gastrointestinal Cancers
By Distribution Channel
By End User
Rest of Europe
Rest of APAC
Rest of LATAM
Rest of MEA
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."